Sensex extends gain to over 200 points, Nifty above 10,600; Sun Pharma up 4%

Sun Pharma to acquire Ranbaxy in $4 billion all-stock deal
Sun Pharma to acquire Ranbaxy in $4 billion all-stock deal

Equity benchmarks extended their gains from the opening minutes, with the Sensex gaining over 200 points, while the Nifty was up over half a percent.

The Sensex is up 202.87 points or 0.59% at 34356.72, and the Nifty up 56.60 points or 0.54% at 10615.50. The market breadth is positive as 1661 shares have advanced, against a decline of 753 shares, while 373 shares are unchanged.

Sun Pharma, Infosys and Lupin gained the most on both indices, while Bharti Airtel and Asian Paints lost the most.

For more information ✆ – 0731-6642300 or Visit http://www.epicresearch.co

Facebook Twitter YouTube Pinterest Linkedin Google+

You may also like:

Sensex, Nifty rangebound; RBI’s MPC meet outcome awaited' width= Sensex, Nifty continue to be sluggish ahead of RBI policy; Europe mixed' width=
Sensex, Nifty rangebound; RBI’s MPC meet outcome awaited Sensex, Nifty continue to be sluggish ahead of RBI policy; Europe mixed
Share Button

About the Author

Epic Research
Epic Research
Epic Research - Investment Adviser is a leading financial services provider with presence in Indian and other global capital markets. Call on - 0731-664-2300